|
|
|
| home > white papers > Maximize the ROI of Your Post-Approval Research - Bioclinica |
|
|
 WHITE PAPERS |
|
|
Bioclinica
|
|
Maximize the ROI of Your Post-Approval Research
|
|
Expenditures in post-approval (Phase IV) research are going up across
the pharmaceutical, biotech and medical device industries. Given the
resources you’ve committed to post-approval research, you may be
wondering if you’re getting the greatest possible return on your
investment.
Discover how to harness the power of post-approval
research to increase data collection, reduce resource burn, save money,
and maximize your ROI!
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
RSSL introduces same-day mycoplasma testing service in UK
Reading Scientific Services Ltd (RSSL), a leading provider of scientific
and technical solutions to the global biopharmaceutical,
pharmaceutical, and biopharmaceutical sectors, has introduced the United
Kingdom’s first same-day mycoplasma testing service for manufacturers
of biologic medicines.
More info >> |
|
 |
White Papers |
 |
|
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
PRA Health Sciences (PRA)
Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >> |
|
 |
Industry Events |
 |
PHARM Connect Congress 2019
12-13 March 2019, Budapest Congress Center, Hungary
PHARM Connect Congress is the premier
networking business event dedicated to pharmaceutical and biotechnology
innovations and trends from development through commercialisation in Central
and Eastern Europe.
The organiser - TEG The Events Group -
cordially welcome all lead business professionals, academicians, researchers
and peers from the field of pharmaceutical manufacturing and biotechnology to
participate in the upcoming Congress.
More info >> |
|
|
|
